Tobacco control framework. by unknown
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
HSE Transformation Programme 
...to enable people live healthier and more fulfilled lives 
 
Easy Access - public confidence - staff pride  
The Health Service Executive 
 
Tobacco Control Framework  
 
February 2010 
 2 
Acknowledgements 
 
It would not have been possible to bring this work to completion without the 
valuable input and contribution of the Tobacco Control Framework Project and 
Steering groups whose stewardship was greatly appreciated. Please see 
appendix 1 and 2 for a list of all members.  
The contribution of staff within smoking cessation and environmental health 
services, other HSE staff who participated in focus groups and staff from 
agencies external to the HSE who participated in consultations to inform this 
document is also greatly appreciated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
Table of Contents 
 
Acknowledgments         2 
Foreword          5 
Introduction          6 
Background to the development of the Tobacco Control Framework  9 
Prevalence of smoking in Ireland - Adults     10 
Prevalence of smoking in Ireland - Children     10 
The health effects of tobacco use       10 
Tobacco use and health inequalities      11 
Economic Considerations        12 
Components of comprehensive tobacco control programmes   12 
 
The MPOWER Model 
Monitor tobacco use and prevention policies     15 
Current situation in Ireland        15 
Monitoring of tobacco prevalence in Ireland      15 
Monitoring the impact of policy interventions      16 
Monitoring of tobacco industry marketing, promotion and lobbying   16 
National Standard - HSE Actions       16 
 
Protect people from tobacco smoke      18 
     Current situation in Ireland        18 
     National Standard - HSE Actions       19 
 
Offer help to quit tobacco use       20 
      Current situation in Ireland        20 
      National Standard - HSE Actions       21 
 
 
 
 4 
Table of Contents 
 
Warn about the dangers of tobacco      23 
     Current situation in Ireland        23 
     National Standard - HSE Actions       24 
 
Enforce bans on tobacco advertising, promotion and sponsorship  26 
    Current situation in Ireland        26 
    National Standard - HSE Actions       27 
 
Raise taxes on tobacco        28 
    Current situation in Ireland        28 
    National Standard - HSE Actions       29 
 
Appendix 1 Members of the Tobacco Control Framework Project Group  30  
Appendix 2 Members of the Tobacco Control Framework Steering Group 31 
Appendix 3 Key developments in tobacco control in Ireland 1964-2009 32 
Appendix 4 Data on smoking prevalence     36 
Appendix 5 Abbreviations        38 
Bibliography          39 
 
Figure 1 Context for Framework Development and Implementation  8 
 
 
 
 
 5 
Foreword 
This framework document was developed by the Health Service Executive (HSE) 
Tobacco Control Framework project group guided by a national steering group in order 
to inform HSE policy and provide a coherent HSE approach to tobacco use in Ireland. In 
developing the Tobacco Control Framework a population health approach has been 
considered as outlined in the HSE’s Population Health Strategy. 
 
Half of all smokers are killed as a direct result of their smoking, and half of them die 
prematurely. On average, smokers lose 10 healthy quality years of life.Tobacco use is a 
significant cause of ill health and mortality in the population. In Ireland smoking kills up to 
6,500 people annually and exacerbates health inequalities. 
 
The HSE will support its management and staff to fully engage with and support this 
framework with a view to understanding their own roles in its implementation.  
The framework has six national standards based on the WHO Report on the Global 
Tobacco Epidemic 2008. That report outlines the MPOWER package, a package of the 
six most important, effective and evidence based tobacco control policies which are: 
Monitoring of tobacco use and prevention policies, 
Protecting people from second-hand smoke, 
Offering help to people who want to quit, 
Warning of the dangers of tobacco, 
Enforcing bans on advertising, promotion and sponsorship, and 
Raising taxes on tobacco.  
 
While the HSE will implement the actions outlined in this framework by seeking to 
address the determinants of tobacco use and reduce health inequalities, it recognises 
that it is not the only sector to play a role in the prevention and treatment of tobacco use. 
Relevant government departments including those responsible for taxation together with 
social and community sectors all play a role. The HSE needs to continue to work and 
support these other relevant sectors at strategic and operational levels to implement the 
national standards that are outside the remit of the health sector.  
Dr Patrick Doorley 
National Director of Population Health 
Health Service Executive 
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Introduction 
Tobacco use is a significant cause of ill health and mortality in the population. In Ireland 
smoking kills up to 6,500 people annually and exacerbates health inequalities. The 
problem of tobacco use has been acknowledged by government at a policy level as 
evidenced by: 
• the implementation of recommendations from Building Healthier Hearts,  
• the development by the Oireachtas Joint Committee on Health and Children of ”A 
National Anti-Smoking Strategy- A Report on Health and Smoking”, 
• their adoption of “Towards a Tobacco Free Society” as a policy document, 
• the passing of the Public Health (Tobacco) Acts 2002, 2004 and 2009 and the 
enactment of various sections of these acts, and 
• their ratification of the World Health Organisation Framework Convention on 
Tobacco Control. 
 
The Health Service Executive (HSE), which provides services that improve, promote and 
protect the health and welfare of the public, is deeply concerned about the harmful 
effects of tobacco use on the population. In its Corporate Plan (2008-2010) it recognises 
the need for a shift towards prevention and better self care rather than a focus on acute 
care and treatment. This will require strong illness prevention initiatives, health 
promotion and population health strategies.  To underscore its commitment in this area, 
smoking prevalence is identified as a key performance indicator in achieving its 
corporate priorities. 
 
Under its Transformation Programme the HSE is committed to tackling the problem of 
tobacco related harm within the population as a whole and in particular in vulnerable 
groups such as children and adolescents and those at the margins of society.  
The HSE has developed this Tobacco Control Framework to provide an evidence based 
approach to address tobacco and to outline national standards for service provision. 
 
In developing the Tobacco Control Framework both the WHO MPOWER principles for 
tobacco control and a population health approach have been considered.  The key 
elements of the population health approach as contained within the HSE’s Population 
Health Strategy * are outlined below: 
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1. Addressing the wider determinants of health and tackling health inequalities, 
2. Planning for health and social well being and not just health and social care 
services, 
3. Developing and employing reliable evidence to improve health and social care 
outcomes, 
4. Making choices for health investment, 
5. Measuring and demonstrating  the return for investment in health and social care 
services,  
6. Shifting the balance from hospital to primary care and health promotion, 
7. Integrating services across the continuum of care, 
8. Proactively engaging and working with other sectors to improve health, 
9. Engaging the population on the issue of their own health. 
 
See Figure 1. for the context of framework development.  
 
* The recommendations contained within this report have considered the nine elements 
of the population health strategy above and will be indicated within the report with an 
astrix followed by the number where appropriate.  (For example *1, *5)  
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Figure 1. Context for Framework Development and Implementation 
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Background to the Development of the Tobacco Control Framework 
 
A steering group was set up in 2007 to guide the development of the Tobacco Control 
Framework. It comprised representatives from the; Population Health Directorate of the 
HSE, Department of Health and Children (DoHC), and the Office of Tobacco Control 
(OTC). The purpose of the steering group was to provide strategic direction in the 
development of the framework. The terms of reference for the steering group were to: 
• Oversee the development of the tobacco control framework. 
• Review best practice in terms of tobacco control nationally and internationally 
with particular reference to how the HSE can develop national standards. 
• Outline the current tobacco control situation in Ireland and actions the HSE will 
take in order to meet best practice standards where required. 
• Advise and support the tobacco control project group on the development of the 
framework.  
• Agree with the tobacco control project group processes for engaging with and 
working in partnership with all relevant stakeholders. 
• Advise on the establishment of the monitoring and evaluation group for the 
framework once the document has been completed. 
 
A project group was also established which included representatives from the three 
service delivery directorates within the HSE. The role of the project group was to carry 
out a literature review on the evidence base in relation to tobacco control, to consult 
extensively with key stakeholders both internal and external to the HSE and to develop 
an outline of the framework document including the development of national standards 
for service provision. Please see Appendix 1 and 2 for project and steering group 
membership. 
 
Whilst much remains to be done in the battle against tobacco, it must be acknowledged 
that there have been considerable inroads into controlling and preventing tobacco use in 
Ireland over the past 50 years or so. These are outlined in Appendix 3.  
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Prevalence of smoking in Ireland 
Adults 
In Ireland the most recent survey of lifestyles and health behaviour SLÁN, 2007 (Brugha 
et al., 2009) found that 29% of adults reported being current smokers (31% men and 
27% women). Younger people were more likely to smoke (35% of those aged 18-29 
years compared with 25% of those aged 45-64). Smoking is also more prevalent among 
lower social class groups. In the 2007 report, 37% reported to be smokers in social class 
group 5-6 compared with 24% reporting to be smokers in the highest social class group 
1-2. The decrease in smoking rates that was evident between 1998 and 2002 has now 
ceased with no reduction in smoking from 2002 to 2007. Overall rates for smoking were 
33% in 1998, 27% in 2002 and now 29% in 2007.  It is estimated that there are 940,000 
adult smokers in Ireland in 2007. 
 
Children 
In the most recent report (Health Behaviour in School Aged Children 2006) which looked 
at smoking prevalence in children and adolescents in Ireland 15% of children overall, 
between the ages of 10 and 17 years reported to be current smokers although this 
varied greatly in the different age categories. Smoking among girls was higher than boys 
for children aged 12-14, with 11.3% of girls aged 12-14 reporting that they were current 
smokers compared with 9.3% of boys the same age. Similarly 27.3% of girls aged 15-17 
reported to be current smokers compared with 21% of boys. There is evidence of an 
overall reduction in reported smoking across all age ranges between the 2002 and 2006 
surveys with the most significant drop of 9.3% in boys aged 15-17 from 30.3% in 2002 to 
21% in 2006. Overall about 63,000 children 10-17 years are current smokers in Ireland. 
 
Further data on smoking prevalence for adults and children is outlined in Appendix 4. 
 
The health effects of tobacco use 
The combined evidence of thousands of published scientific papers confirms that there 
is undisputable evidence that tobacco use has detrimental health effects for those who 
use tobacco and for those exposed to second-hand smoke (SHS).  Worldwide, tobacco 
killed more than 100 million people during the 20th century and it is estimated that it will 
kill more than one billion people in the 21st century; about 5.4 million people a year from 
lung cancer, heart disease and other illnesses.  
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Half of all smokers are killed as a direct result of their smoking, and half of them die 
prematurely. On average, smokers lose 10 healthy quality years of life. In Ireland 
smoking kills up to 6,500 people annually. By virtue of the mortality caused by smoking 
and the many acute and chronic illnesses caused and exacerbated by smoking, it places 
a huge burden on individuals, their families and friends, the health and social services 
and on society. On a positive note, the evidence base is also fairly clear that quitting 
smoking brings many benefits. 
 
Tobacco use and health inequalities 
Large proportions of our society particularly those living in underprivileged communities 
remain exposed to the significant health risks from smoking. Smoking not only has 
detrimental health effects, but is also a contributory factor in poverty and health 
inequalities. Money spent on tobacco by those with low incomes means money not 
spent on basic necessities such as food, shelter, education and health care.  
 
There is a strong relationship between tobacco use and health inequalities. Smoking 
rates are higher among lower socio-economic groups than in more affluent groups. It 
has been shown that because of the severe health effects of tobacco use, this 
contributes greatly to socio-economic differences in health. In Britain cohort studies 
following participants over two decades have revealed that those from unskilled and 
manual backgrounds were more likely to be current smokers than those from 
professional and non manual backgrounds. A World Bank report on the economics of 
tobacco analysed the impact of smoking on the survival of men of varying social classes 
in four countries where smoking is an established social norm – Canada, Poland, the 
United Kingdom and the United States.  In Poland in 1996 it found that men with a 
University degree had a 26% risk of death in middle age compared to a 52% risk for men 
with just primary level education. Tobacco was responsible for about two thirds of the 
excess risk in the group of men with primary level education.  
 
Ireland is no different in that lower socio-economic groups have higher smoking 
prevalence rates as outlined earlier and therefore smokers in lower socio-economic 
groups have poorer health outcomes.  
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Economic Considerations 
The social and economic cost of smoking is detrimental to society in terms of time lost 
from work due to tobacco related diseases, productivity losses, medical, disability and 
mortality costs.  In high income countries like Ireland smoking related health care costs 
account for between 6% and 15% of all annual healthcare costs.  
An Australian study conducted by Hurley & Matthews in 2007 developed a ‘Quit Benefits 
Model’ which assessed the consequences of quitting smoking in terms of the avoided 
cases of four smoking related diseases; acute myocardial infarction, stroke, lung cancer 
and chronic obstructive pulmonary disease. It also reports on the quality adjusted life 
years (QUALYs) and health care costs saved and the tool can be adapted for use in 
other countries as an evaluation tool. The study found that for every 1,000 smokers who 
quit smoking there was an average saving of A$373,000 in health care costs associated 
with the four medical conditions above. Overall forty of these individuals would be 
spared a diagnosis of four of the most common smoking related diseases and eighteen 
deaths prevented per 1,000.  Therefore not only is it important from a health protection 
and promotion perspective to address tobacco use in a comprehensive way, reducing 
tobacco consumption will also save the health services and general economy millions. 
 
Components of comprehensive tobacco control programmes 
In addition to the thousands of peer reviewed scientific papers on the harmful effects of 
tobacco use, there are thousands more which evaluate the effectiveness or otherwise of 
methods to reduce the prevalence of tobacco use. 
 
The World Health Organisation has carried out a comprehensive analysis of the 
research and has identified the key strategies countries need to adopt to reduce tobacco 
use. These are outlined in some detail in the WHO Report on the Global Tobacco 
Epidemic 2008. In that report it outlines the MPOWER package, a package of the six 
most important, effective and evidence based tobacco control policies which are: 
 
 
Monitoring of tobacco use and prevention policies, 
Protecting people from second-hand smoke, 
Offering help to people who want to quit, 
Warning of the dangers of tobacco, 
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Enforcing bans on advertising, promotion and sponsorship, and 
Raising taxes on tobacco.  
 
Most of these same measures were recommended in previous reports published by the 
World Bank and the US Department of Health and Human Services. Some of these 
measures the HSE can implement itself, for others it will need to work in partnership with 
other interested parties and for others it will need to advocate to government for action.  
 
The HSE Tobacco Control Framework is modelled on the six proven policies contained 
within the MPOWER report as well as the nine elements of the Population Health 
Strategy. These are outlined below. For each of the six areas identified, the current 
situation is outlined followed by the National Standards which have been set and the 
actions the HSE needs to put in place in order to maximise the effect of these broad 
policy statements. 
 
In addition, the HSE in recognising the need to work in partnership with other bodies will 
establish a national expert group on tobacco control in partnership with key stakeholders 
to assist in the development of a coordinated national approach to address tobacco use. 
This national expert group will include representation from the Department of Health and 
Children, the OTC and various other non governmental organisations which have an 
interest in tobacco control. The group will help coordinate and communicate work within 
the various bodies and avoid duplication of tobacco control work.   
 
The timeframe for implementing this framework is five years. A yearly implementation 
plan will be developed which will outline how the framework will be implemented. The 
priorities and action areas in this document will be implemented using a well structured 
project management approach linked to the Transformation Programme * of the HSE. It 
will also cross reference and complement other projects within Programme 4 (Implement 
a model for the prevention and management of chronic illness and improve the health of 
the population). Other projects which are included in programme 4 include the following: 
 
 
• Develop and implement a health inequalities framework, 
• Develop and implement a chronic illness framework, 
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• Develop and implement a population health strategy, 
• Develop and implement a framework for action on obesity, 
• Implement the 5 year strategic action plan on breastfeeding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* The Transformation Programme 2007-2010 consists of six transformation priorities. 
They are as follows: 
 
1. Develop integrated services across all stages of the care journey, 
2. Configure primary community and continuing care services so that they deliver 
optimum and cost effective results, 
3. Configure hospital services to deliver optimum and cost effective results, 
4. Implement a model for the prevention and management of chronic illness and 
improve the health of the population, 
5. Implement standards based performance measurement and management 
throughout the HSE, 
6. Ensure all staff engage in transforming health and social care in Ireland. 
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The MPOWER Model 
 
1- Monitor tobacco use and prevention policies 
Data from monitoring is necessary to ensure the successes of the five other policy 
interventions in the MPOWER package. Comprehensive monitoring of the tobacco 
problem informs those involved in tobacco control at every level about the size of the 
problem we face. It also shows whether various policies are working and how they 
need to be tailored to the population. 
 
Good monitoring systems need to track several indicators, including 
- prevalence of tobacco use, 
- impact of policy interventions, 
- tobacco industry marketing, promotion and lobbying. 
 
Current situation in Ireland 
Agencies other than the HSE are directly involved and funded for monitoring of 
tobacco use and prevention polices 
 
Monitoring of tobacco prevalence in Ireland 
Ireland has at its disposal three ongoing measures of smoking prevalence which 
provide prevalence data by gender, age, and socio economic status.  These include 
the SLÁN and Health Behaviour in School Aged Children (HBSC) surveys, both of 
which are published every four years. In addition the OTC carries out a monthly 
monitoring rolling telephone survey on smoking prevalence which is also weighted by 
geographic area. 
 
Data is also available from the Revenue Commissioners as to the quantity of tobacco 
products sold on an annual basis and the tax receipts from tobacco sales. 
 
Other surveys - once off research studies (e.g. ISAAC) and EU surveys may also 
present data on tobacco prevalence. 
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Monitoring the impact of policy interventions 
Research carried out by the OTC and other research bodies monitor the 
effectiveness of policy interventions – e.g. studies on the effectiveness of the smoke 
free at work tobacco legislation introduced in 2004. The OTC conducted a baseline 
survey in 2007 providing a national overview of behaviour among tobacco retailers in 
respect of sales to minors’ legislation as set out in the Public Health (Tobacco) Acts 
2002 to 2009. This survey, which was repeated in 2008 and 2009, enables tobacco 
control progress in the retail environment to be monitored.   
Research is also carried out on the impacts of social marketing campaigns and the 
operation of the Quitline. The Environmental Health Services of the HSE and the 
OTC monitor compliance with the 2004 smoke free at work tobacco legislation and 
report compliance levels on an annual basis. 
 
Monitoring of tobacco industry marketing, promotion and lobbying 
The OTC ensures that that the tobacco industry in Ireland is closely monitored in 
terms of its marketing, promotion and lobbying practices.  
As a result of the ongoing surveys and monitoring outlined above, the HSE has 
access to significant data on tobacco use and prevention polices; however, there are 
gaps in that data. In the first instance definitions of smoking for prevalence surveys 
often differ. In addition, more robust local data would assist in targeting resources at 
areas of maximum need.  
 
National Standard  - HSE Actions 
In order to support the MPOWER policy of monitoring tobacco use and prevention 
polices the HSE will: 
1.1 Seek to analyse SLÁN, HBSC (4 yearly intervals), OTC surveys and other 
research findings on tobacco prevalence when such data becomes available with 
a view to targeting interventions appropriately. (*3) 
1.2 Make the output from the analysis mentioned above widely accessible to the 
public and health care professionals by placing it on the HSE website. (*9) 
1.3 Work with all stakeholders to get an agreed definition of smoking for use in 
future prevalence surveys. (*8) 
 
 17 
1.4 Advocate for the introduction of a common definition of a smoker/ tobacco 
user for all surveys on tobacco prevalence and that tobacco use prevalence 
statistics are available more frequently (every two years). (*3) 
1.5 Develop structures and implement mechanisms to ensure that the tobacco 
use, smoking status and exposure to SHS of service users is routinely recorded 
along with the interventions applied by HSE health professionals to assist 
cessation. (*6) 
1.6 Develop a process to monitor the prevalence of tobacco use among HSE 
staff. (*3) 
1.7 Monitor on a frequent basis the roll out and sustainability of in-house HSE 
tobacco policies. (*4) 
1.8 Develop evidence based audit methodology to evaluate the provision of 
tobacco cessation services, the work of cessation providers and the outcomes of 
the services. (*5) 
1.9 Develop and audit all social marketing campaigns to the standard set out in 
the Campaign Development Tool Kit - International Guide for Planning and 
Implementing Stop Smoking Campaigns. (*3) 
1.10 Ensure that systems are put in place to facilitate the Environmental Health 
Services in operating a more streamlined national approach to the collection, 
collation and auditing of data in checking the compliance or otherwise with 
tobacco control legislation. (*3) 
1.11 Support research to improve the monitoring of tobacco use and prevention 
policies. (*3) 
      1.12 Engage with the relevant stakeholders to establish a national expert group 
      on tobacco control which will help coordinate and communicate work within the 
      various bodies and avoid duplication of tobacco control work. (*8) 
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2 - Protect people from Tobacco Smoke 
Research clearly shows that there is no safe level of exposure to SHS. Numerous 
health organisations concur that SHS exposure contributes to a range of diseases, 
including heart disease and many cancers. For example, SHS exposure increases 
the risk of coronary heart disease by 25–30% and the risk of lung cancer in non-
smokers by 20–30%. 
 
The US Surgeon General’s report in 2006 reviewed research on exposure to SHS 
and concluded that complete smoke free policies were the most economic and 
effective approach for providing protection from exposure to SHS and that they 
provide the greatest health impact.  
 
Current Situation in Ireland 
Legislation which came into force on the 29th March 2004 prohibits smoking in most 
workplace settings. HSE Environmental Health Services and the OTC have 
developed a National Tobacco Control Inspection Programme to monitor the 
legislation. In 2008, 97% of workplaces inspected were found to be compliant with 
the legislation. 
 
However, the legislation does not protect all persons from exposure to SHS equally. 
There were some exceptions contained within the legislation. It does not extend to 
cover smoking within HSE residential and day-care services: mental health services, 
community hospitals, nursing homes, intellectual disability services and the prison 
services. As a result clients and employees within these services remain exposed to 
SHS.  In order to address some of these issues, in 2008 the HSE in conjunction with 
the Irish Health Promoting Hospital Network finalised and launched Best Practice 
Guidelines for Tobacco management in the Mental Health Setting.  The HSE have 
made a commitment to implement these guidelines in mental health services 
nationally. 
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National Standard  - HSE Actions 
In order to support the MPOWER policy of protecting people from tobacco smoke the 
HSE will: 
2.1 Develop and implement a tobacco free policy applicable to all its services. (*6) 
2.2 Under the above policy develop a protocol to protect all staff from SHS where 
service provision includes going into a domestic setting. (*6) 
2.3 Put procedures in place to protect children under the care of the HSE from 
SHS in all settings. (*2) 
2.4 Implement the comprehensive standards for health services as defined by the 
European Network of Smoke Free Health Care Service (ENSH) standards. (*6) 
2.5 Through their Environmental Health Service continue with a uniform approach 
throughout the HSE to implement the National Tobacco Control Inspection 
Programme Protocols which relates to compliance with the smoke free at 
work legislation. (*4) 
2.6 Sustain and further develop social marketing campaigns to inform the public 
on the dangers of SHS and how they might mitigate that danger to 
themselves and others. (*9) 
2.7 Work with the Department of Health and Children to enhance the legislation in 
order to further protect people from the hazards of SHS, especially those not 
covered under existing legislation. (*2) 
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3- Offer help to quit tobacco use 
Nicotine is the highly addictive drug contained within tobacco and understanding it 
and the nature of addiction can ultimately help when supporting smokers to quit.  
Smokers who try to quit smoking without support have a less than 2% chance of 
quitting successfully after one year. There are a range of different treatments and 
supports to help smokers quit.  
 
In addition to the MPOWER report, two comprehensive and evidence based sources 
of information on best practice were consulted to decide the best practice standards 
for promoting smoking cessation for this framework document. These included the: 
- National Institute for Health and Clinical Excellence (NICE) Public Health 
Guidance on Smoking Cessation Services,  
- Cochrane systematic reviews of published and peer reviewed papers on 
smoking cessation. 
 
There are seven proven smoking cessation activities or inventions.  
These include: Brief interventions, Individual behavioural counselling, Group 
behaviour therapy, Pharmacotherapies, Self help materials, Telephone counselling 
via quitlines, and Mass media campaigns. 
 
Current Situation in Ireland  
The HSE funds the National Smokers Quitline which in conjunction with the Irish 
Cancer Society provides a smoking cessation support service Monday to Saturday 
from 8am to 10pm. This provides the public with access to a telephone support 
service from a trained smoking cessation counsellor.  
The Research Institute for a Tobacco Free Society conducted comprehensive 
research on smoking cessation services provided directly by the HSE during 
2007/08. Data from that research shows that where direct smoking cessation 
services are available, those who carry out the services do so to a high standard. 
However, the provision of direct smoking cessation support services is sub-optimal 
and very patchy throughout the country. In addition, the research found that the 
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collection, collation and analysis of follow up data varied among providers as there is 
little in the way of standardisation as to how such data are managed.  
Whilst GPs and others provide some smoking cessation service, there are no data on 
the extent that this happens, the skill base of those who provide the service or the 
uptake and outcome of such services. 
 
Finally, nicotine replacement therapies, buproprion and varenicline are available by 
prescription free to all GMS registered patients who smoke. For the remainder of the 
smoking population, buproprion and varenicline are subsidised via the Drugs 
Payment Scheme.  
 
National Standard  - HSE Actions 
In order to support the MPOWER policy of offering help to quit tobacco use the HSE 
will: 
3.1 Further develop the skills of all trainers who deliver tobacco cessation training so 
       that they themselves are trained to a satisfactory standard. (*3) 
3.2 Develop national tobacco cessation training standards for use by all health and 
       social care professionals. (*3) 
3.3 Provide nationally recognised and accredited Brief Interventions training to all        
front line health care staff and primary care staff. (*6) 
3.4 Incorporate tobacco cessation services into both primary care and front line 
services making the delivery of brief advice and referral to specialist services a 
core role for staff working in these areas. (*7) 
3.5 Further develop tobacco cessation services so that that all health care providers 
delivering tobacco cessation support/services (either through specialist services 
or primary care) adhere to a set of nationally agreed standards/guidelines and 
that consistent service provision is delivered nationally. (*3) 
3.6 Develop and extend tobacco cessation services specifically targeting areas of 
inequalities and high smoking prevalence using trained lay health advocates. (*1) 
3.7 Advocate to third level institutions and health professional associations for the 
compulsory introduction of brief intervention training/tobacco cessation training in 
all undergraduate and postgraduate education across all health disciplines. (*8) 
3.8 Incorporate information on supports available to people to stop smoking when 
developing social marketing campaigns. (*9) 
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3.9 Further develop multimedia smoking cessation tools. (*4) 
3.10 Maintain an active register of specialist tobacco cessation service providers. (*3) 
3.11 Work towards the integration of services in all regions and prioritise areas of 
highest smoking prevalence i.e. lower socio-economic areas, also mental heath and 
maternity settings when planning and delivering tobacco cessation services. (*1) 
3.12 Set realistic performance targets for both the number of people using the 
service and the proportion who successfully quit smoking and tobacco use based on 
the demographics of the region. (*5) 
3.13 Produce a simple clear resource for GPs and pharmacists on tobacco 
cessation. (*6) 
3.14 Maintain an efficient Quitline service with computerised recording of tobacco 
use, smoking status and interventions along with cessation follow up monitoring data.  
3.15 Continue to provide evidence based pharmacotherapy free to GMS patients. (*4) 
3.16 Use social marketing methodologies to advertise the availability of free nicotine 
replacement products under the GMS scheme. (*9) 
3.17 Advocate for the introduction of all evidence based pharmacotherapy including 
nicotine replacement therapy on the drug refund scheme. (*4) 
3.18 Encourage health insurers to provide refunds to their clients for evidence based 
pharmacotherapy medicines used to support smoking cessation. (*8) 
3.19 Advocate for nurse prescribing of evidence based smoking cessation 
pharmacotherapy medicines. (*6) 
3.20 Sustain and develop social marketing campaigns to advertise the Quitline 
tobacco cessation service. (*9) 
3.21 Support research into new ways of supporting tobacco users and smokers to 
quit particularly targeting disadvantaged communities where tobacco use and 
smoking rates are higher. (*3) 
3.22 Actively support HSE staff who wish to quit smoking. (*2) 
3.23 Work with procurement services to introduce stop smoking messages on all 
newly printed HSE stationery. (*9) 
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4 - Warn about the dangers of Tobacco 
The international evidence base points to the need for governments and health 
services to change the image of tobacco. People need to see that tobacco is 
extremely addictive with dangerous health consequences and is socially undesirable.  
Despite conclusive evidence on the dangers of tobacco, relatively few tobacco users 
worldwide fully grasp its health risks. People may know generally that tobacco use is 
harmful, but it is usually seen merely as a bad habit in which people choose to 
indulge. The extreme addictiveness of tobacco and the full range of health dangers 
are not adequately understood by the public. Consequently, people believe they can 
reduce or stop tobacco use before health problems occur. The reality is that most 
tobacco users will find it extremely difficult to quit, and up to half will die from 
tobacco-related illnesses. Most people are unaware that even the smallest level of 
tobacco use is dangerous, in part because this is not the case with other behavioural 
health risks. Many tobacco users cannot name specific diseases caused by smoking 
other than lung cancer, and do not know that smoking also causes heart disease, 
stroke and many other diseases, including many types of cancer. Comprehensive 
warnings about the dangers of tobacco are critical to changing its image, especially 
among adolescents and young adults. People need to associate tobacco with its 
extreme addictiveness and dangerous health consequences, and to see it as socially 
undesirable and negative.  
 
The US Centers for Disease Control and Prevention recommend that governments 
generally spend US $2–4 per person per year on anti-tobacco health communication 
and counter-advertising efforts, which research shows is very effective at reducing 
tobacco use. This type of advertising should comprise about 15%–20% of total 
tobacco control programme costs.  
 
Current Situation in Ireland  
There have been a number of social marketing campaigns developed in Ireland over 
the past number of years. These include the ‘Break the Habit for Good: NICO’ 
campaign which commenced in 2000 focusing on youth, the 2004 OTC campaign on 
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the dangers of SHS and the 2003/2004 “Every Cigarette is doing you Damage” 
campaign. ‘The Beauty of Quitting’ campaign in 2007 focused specifically on young 
women and the negative effects of tobacco use on their image. 2007 and 2008 saw 
social marketing campaigns to promote the National Smoking Cessation Quitline. In 
2009 a radio, billboard and television campaign was launched which targeted parents 
and guardians encouraging them to think about how their smoking effects and 
influences their children. In addition the EU has worked closely with Member States 
in warning about the dangers of tobacco through its “Feel Free to Say No” and 
“HELP” campaigns.  
 
The HSE inputs into the Department of Education and Science’s health education 
programme entitled SPHE (Social, Personal and Health Education) which has a 
tobacco element. It provides written materials on the harms from tobacco use and 
cessation support materials which are widely circulated.  The HSE has also 
developed an online element which makes up part of the multimedia approach to the 
promotion of smoking cessation. This includes elements to address the needs of 
young people and the general public and includes both internet and HSE intranet 
components. Appropriate promotional activity is planned to raise the profile of this 
support.  
 
Through its Environmental Health Services, it provides an important educational 
support base for retailers of tobacco products and bar owners on the dangers of 
tobacco and associated SHS. 
 
Health warnings on the packaging of all tobacco products are guaranteed to reach all 
users. Health warnings on tobacco packages increase smokers’ awareness of their 
risk. Use of pictures with graphic depictions of disease and other negative images 
has greater impact than words alone, and is critical in reaching the large number of 
people who cannot read. Pack warnings in Ireland are dual language and a 
consultation process has recently been completed regarding the introduction of 
pictorial pack warnings. 
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National Standard  - HSE Actions 
In order to support the MPOWER policy of warning about the dangers of tobacco the  
HSE will: 
4.1 Formulate sustainable 3-5 year social marketing campaigns to address tobacco 
issues using best evidence as outlined in the Campaign Development Tool Kit 
and recommendations from the NCI Tobacco Control Monograph 19 - The role of 
the media in promoting and reducing tobacco use. (*3) 
4.2 Progress an awareness campaign to advise all HSE staff of the dangers of 
tobacco use. (*6) 
4.3 Maximise the health promoting ability of its 100,000 plus staff in order to ensure 
that the wider community are aware of the dangers of tobacco use. (*6) 
4.4 Ensure that information disseminated on the harm from tobacco use also 
includes information on the health risks associated with exposure to SHS. (*9)  
4.5 Work in partnership with other agencies to deliver comprehensive coordinated 
public awareness messages in relation to tobacco use. (*8) 
4.6 Continue to encourage and support the use of the SPHE tobacco module at all 
schools. (*8) 
4.7 Continue to support and engage with the ‘Campaign Advisory Group’ which is a 
national expert group made up of staff working in the areas of tobacco both within 
the HSE and from external stakeholders to develop anti tobacco advertisement 
campaigns including counter advertising (*8) 
4.8 Promote the Quitline service through multimedia channels. (*9) 
4.9 Through its Environmental Health Services, deliver retailer education campaigns 
on the dangers of tobacco and the need for compliance with legislation in order to 
raise awareness of the retailer’s responsibility in relation to the sale of tobacco 
products to minors. These education campaigns will give priority to areas where 
sales to minors are known to have occurred in the past and to retailers located 
near schools and in disadvantaged and lower socioeconomic areas. (*1) 
4.10 Use HSE infrastructural facilities (transport, buildings etc) as a resource to 
       assist in running social marketing campaigns on the dangers of tobacco use. (*6) 
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5 - Enforce bans on tobacco advertising, promotion and 
sponsorship 
Comprehensive advertising bans reduce tobacco use among people of all income 
and all educational levels. A ban on marketing, sponsorship and promotion is a 
powerful weapon against the tobacco industry and the tobacco epidemic generally. 
In order to comply with best practice and be effective, bans must be complete and 
apply to all marketing and promotional categories.  
 
Current Situation in Ireland  
Advertising of tobacco products is restricted under the Tobacco Products (Control of 
advertising, sponsorship and sales promotion) Regulations 1991, 1996 and 2000 and 
by the Public Health (Tobacco) Acts 2002 to 2009. From 1 July 2009 no advertising 
or display of tobacco products is permitted. Tobacco products must be out of view 
within a closed container or dispenser only accessible by the retailer and retail staff. 
Self-service vending machines are prohibited except in licensed premises and 
registered clubs and must be operated in accordance with Regulations. All retailers 
wishing to sell tobacco products must register with the Office of Tobacco Control. 
Section 33 of the Public Health (Tobacco) Acts 2002 to 2009 provides that a person 
who advertises or causes the advertisement of a tobacco product in contravention of 
Directive 2003/33/EC shall be guilty of an offence.  
Sales of tobacco products to minors are also illegal. The OTC has developed an 
Information Guide for Retailers and Staff which commenced in 2008 and outlines the 
law in relation to sales to minors, together with frequently asked questions.  The 
information guide is available in English, Irish, Chinese (Mandarin) and Polish. In 
addition to the guide a training DVD for retailers and staff was also produced and 
circulated both directly to tobacco retailers from the OTC and through Environmental 
Health Departments nationally. A media campaign highlighting the availability of 
these resources was also developed using radio advertising on both national and 
regional radio stations. The Public Health (Tobacco) Acts 2002 to 2009 introduced a 
ban on advertising or display of tobacco products with some exemptions for specialist 
and duty free stores. 
 27 
  
National Standard  - HSE Actions 
In order to support the MPOWER policy of enforcing bans on tobacco advertising, 
promotion and sponsorship the HSE will: 
5.1 Continue to engage with the OTC and the DoHC in updating Environmental 
Health staff on policy implementation issues which are specifically targeted within 
agreed business plans. (*8) 
5.2 Through its Environmental Health Services submit quarterly reports to the OTC 
outlining the figures on the activities and outcomes of the National Tobacco 
Control Inspection Programme for example: the numbers of inspections and non 
compliant premises along with details of enforcement actions taken. (*5) 
5.3 Through its Environmental Health Services roll out the National Tobacco Control 
database which will improve the efficiency and consistency of data collation and 
provide for regular reports to the OTC on activities and outcomes from the 
inspection programme. (*4) 
5.4 Continue to engage with the OTC and the DoHC to review the National Tobacco 
Control Inspection Programme Protocols in light of the introduction of new 
legislation in relation to point-of-sale advertising and the formulation of a tobacco 
retail register. (*8) 
5.5 Prioritise and allocate environmental health staff within the HSE to police all 
legislation in relation to tobacco(*6) 
5.6 The HSE will investigate the possibility of publicising on the HSE website the 
names and addresses of those premises convicted of being non-compliant with 
the relevant legislation. (*9) 
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6 - Raise taxes on tobacco  
Raising the price of tobacco products is the single most effective measure to reduce 
tobacco consumption and encourage tobacco users to quit. It is also the most cost 
effective and successful measure to tackle health inequalities resulting from tobacco 
use. 
Increases in tobacco excise taxes by 10% worldwide would according to the World 
Bank reduce demand for cigarettes by about 4% in high income countries like 
Ireland.  Young people, minority groups and low income smokers in particular are 
‘two to three times more likely to quit or smoke less in response to price increases’ . 
Tax increases also benefit governments by increasing revenues which can be used 
for tobacco control. The most effective type of tax increase is one that is levied on a 
given quantity of tobacco such as a tax paid per pack of cigarettes. Taxes should be: 
• Regularly adjusted for inflation and consumer purchasing power in order to 
maintain their ability to reduce tobacco use. 
• Applied at the manufacturer level and certified by a stamp rather than being 
levied at the wholesale or retail level to reduce administrative costs on these 
smaller businesses and reduce the possibility of evasion. 
• Applied to all tobacco products on a pro rata basis to avoid substitution from 
more expensive tobacco products such as cigarettes onto cheaper tobacco 
products.  
 
Current Situation in Ireland  
Ireland has one of the highest tax takes on cigarettes in the EU with the tax 
component of the price of a pack of twenty cigarettes now set at over 70%.  The HSE 
does not have the ability to adjust the tax on tobacco products and can only advocate 
to government for tax increases pointing out its importance as one of the most 
significant and effective tobacco control measures. 
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National Standard  - HSE Actions 
In order to support the MPOWER policy of advocating for further increases in price 
on tobacco products the HSE will: 
6.1 Continue to play a significant role in encouraging government to increase the 
price of tobacco products and remove tobacco products from the consumer 
price index. (*8) 
6.2 Prepare pre budget submissions on an annual basis outlining the cost 
effectiveness and health benefits of increasing taxes on tobacco products. (*8) 
6.3 Support research which strengthens the argument for raising the price of 
tobacco products. (*3) 
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Appendix 1 – Members of Tobacco Control Framework Project Group 
 
Dr Fenton Howell - Director of Public Health, Population Health (Joint Chair) 
 
Ms. Maria Lordan Dunphy - Health Promotion Development Manager, Population Health 
(Joint Chair) 
 
Ms. Ann O’ Riordan / Miriam Gunning - Irish NPH Network, Population Health  
 
Ms. Imelda O’Neill - Senior Health Promotion Officer, HSE Dublin Mid Leinster 
 
Mr. Paul Hickey Senior Environmental Health Officer, HSE West  
 
Ms. Geraldine Hanna - Health Promotion Functional Manager: Communication, Social  
Marketing & Advocacy 
 
Mr. William Ebbitt - Health Promotion Functional Manager: Policy and Strategy 
 
Ms. Teresa Hanrahan – General Manager Wexford County Hospital 
 
Ms. Biddy O’ Neill - Health Promotion Functional Manager: National Health Promotion 
Programmes 
 
Ms. Martina Blake- Project Manager Tobacco Control Framework, Health Promotion, 
HSE South 
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Appendix 2 – Members of the Tobacco Control Framework Steering Group 
 
Ms. Cathérine Murphy Assistant National Director Population Health, Health Promotion 
(Joint Chairperson) 
 
Mr. Martin Devine Assistant National Director Population Health, Environmental Health 
(Joint Chairperson) 
 
Mr. Eamonn Rossi CEO, Office of Tobacco Control 
 
Mr. Robbie Breen – Assistant Principal Officer, Health Promotion Policy Unit, Dept of 
Health and Children 
 
Ms. Siobhan McEvoy – Acting Chief Environmental Health Officer, Dept of Health and 
Children 
 
Ms. Maria Lordan Dunphy, Health Promotion Development Manager, Population Health  
 
Dr. Fenton Howell, Director of Public Health, Population Health  
 
Mr. Dave Molloy, Area Chief EHO, Dublin North East  
 
Mr. Richard Dooley, Hospital Network Manager, HSE South 
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Appendix 3 – Key developments in tobacco control in Ireland 1964-2009 
1964 A voluntary code on advertising was introduced. 
1971 Tobacco advertising was banned on Television. 
1978 The Tobacco Products Control of Advertising, Sponsorship and Sales Promotion 
Act 1978 was enacted 
1988 The Health Promotion and Protection Act was passed which banned the sale of 
tobacco products to under 16 year olds and made the sale of smokeless tobacco 
products illegal in Ireland 
1991 Regulations under the 1978 Act set out that advertising could only take place 
internally in premises at points of retail sale provided the advertising did not use 
electronic media or sound. 
Advertising in print media which was directed primarily at under 18’s was banned. 
Health warnings were introduced on tobacco products.  
Tobacco industry sponsorship and selling cigarettes at discount prices was 
restricted.  
1994 Shaping a Healthier Future - a strategy for effective healthcare in the 1990s’ was 
published and set targets for a reduction in smoking prevalence. 
A Smoking Target Action Group (STAG) was set up by the CEOs of the health 
boards in response to the targets set out for tobacco control in the health 
strategy. Its membership included representatives from the Office for Health 
Gain, the eight health boards, the Department of Health and Children, the Irish 
Cancer Society, the Irish Heart Foundation and ASH Ireland. The function of the 
STAG group was to co-ordinate work towards achieving the reduction in smoking 
levels targeted in the National Health Strategy of 1994. 
Further amendments to the list of health warnings on tobacco products were 
enacted. 
1997 The Irish Cancer Society established the ‘Quitline’ service to support smokers in 
quitting. Subsequently they entered into partnership with the Health Boards and 
Eastern Regional Health Authority to provide this service. The service is now 
funded by the HSE. 
1999 The Department of Health and Children published Building Healthier Hearts, a 
national strategy for dealing with heart disease. It included recommendations in 
tackling the tobacco epidemic, with particular emphasis on cessation supports. 
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The Oireachtas Joint Committee on Health and Children published ‘A national 
anti-smoking strategy – A Report on Health and Smoking. 
Budget increase of 50 pence (64 cent) on the price of a packet of cigarettes (16% 
increase) to help fund Building Healthier Hearts 
2000 The DoHC Tobacco Free Policy Review Group published their report on Health 
and Tobacco ‘Towards a Tobacco Free Society’, 
European Ministers enact new laws on disclosure of content in tobacco products 
and ensures that warnings about the dangers of the product are to be included 
on each pack.  
A ban on all tobacco advertising in the print media other than limited retail and 
trade advertising was introduced in Ireland. Sponsorship by tobacco companies 
was also ended. 
The Office of Tobacco Control was set up on an administrative basis. 
The Research Institute for a Tobacco Free Society (RIFTFS) was established to 
form a transdisciplinary academic community around the issue of tobacco control 
and to support the development of a tobacco free society by engaging in all 
aspects of research from a public health perspective. 
2001 Joint Oireachtas Committee on Health and Children published 2nd report on 
Smoking 
The Public Health Tobacco Bill (2001) was published.  
Free nicotine replacement therapy for medical card holders was introduced.  
The legal age at which a person can be sold tobacco products was raised to 
eighteen years. 
2002 The Public Health (Tobacco Act), 2002 was passed. 
The Office of Tobacco Control became a statutory body.  
2003 The report on ‘The Health Effects of Environmental Tobacco Smoke in the 
Workplace’ was published by the Health and Safety Authority (HSA) and the 
Office of Tobacco Control (OTC). 
World Health Assembly adopted the Framework Convention on Tobacco Control 
(FCTC)  
The European Communities Manufacture Presentation and Sale of Tobacco 
Products Directive was transposed into Irish Law. This set out the nicotine and 
tar levels in tobacco products, and imposed certain restrictions on the colour font 
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of tobacco advertising on products as well as setting a minimum size for health 
warnings.   
Hospitals and health services working within the Irish HPH Network adopt and 
commence implementation of the European Network of Smoke Free Health Care 
Service (ENSH) standards. These standards include in addition to tobacco 
control, staff training and education, development of cessation services and 
systematic monitoring and review procedures for tobacco policies 
2004 The Public Health (Tobacco) (Amendment) Act 2004 (Commencement) Order 
2004 came in to operation. It banned smoking in specified enclosed buildings in 
order to protect the public from second-hand smoke (SHS). It made it compulsory 
to display no smoking signage and made it an offence to obstruct the work of an 
environmental health officer who was trying to ensure compliance.  
An EU Conference on the ‘Future Directions in Tobacco Control’ was hosted in 
Ireland by the Office of Tobacco Control, the EU Commission, the Department of 
Health and Children and the Mid Western Health Board. 
2005 The Irish government ratified the World Health Organisations’ Framework 
Convention on Tobacco Control (FCTC).   
2006 The High Court (Mr Justice Roderick Murphy) supported the protocol which 
facilitates Environmental Health Officers of the HSE in using children to test-
purchase cigarettes in retail outlets.  
An EU Court of Justice decision ensures that individuals must continue to pay 
domestic custom duties when buying tobacco products from another EU country 
and having it delivered to their home. 
2007 A number of plaintiffs, including PJ Carroll & Company Ltd, John Player & Sons 
Limited and Gallaher (Dublin) Limited,  discontinued their legal challenge to key 
provisions of the Public Health (Tobacco) Acts 2002  and 2004. The plaintiffs 
agreed that it was appropriate for the Court to make an order that the plaintiffs 
would pay the full costs of the state in relation to the litigation. 
Sections 38(1) and 38(3) of the Public Health (Tobacco) Acts 2002 to 2009 were 
commenced banning the sale of cigarettes in packets of less than 20 and 
confectionary which resembles tobacco products. 
Hospitals and health services working within the HSE Irish HPH Network work 
towards the full implementation of the revised European Network of Smoke Free 
 35 
Health Care Service Standards (ENSH) that moves health services towards 
being totally tobacco free. 
HSE Tobacco and Mental Health Services develop at National and European 
level a set of Guidelines for Tobacco Management in the Mental Health Setting. 
2008 Guidelines for Tobacco Management in the Mental Health Setting are launched 
and endorsed for implementation within all HSE Mental Health Services.  
It is announced that further provisions of the Public Health (Tobacco) Acts 2002 
and 2004 are to be commenced on 1 July 2009 which relate to in store 
advertising of tobacco products  
Dual language health warnings (Irish and English) on tobacco products 
commence. 
Public consultation takes place on graphic pictorial warnings. 
2009 St Vincent’s Hospital entire campus in Dublin 4 became a no smoking zone on 
January 1, 2009. Connolly Hospital, Blanchardstown became smoke free on  the 
31st May 2009. The IMO calls on all health sector organisations to follow the 
leadership shown by St. Vincent’s Hospital in making their respective campus’ 
smoke-free. 
From 1 July 2009 no advertising or display of tobacco products is permitted in 
retail outlets with some exemption for specialist and duty free stores. Tobacco 
products must be out of view within a closed container or dispenser, only 
accessible by the retailer and retail staff. Self-service vending machines are 
prohibited except in licensed premises and registered clubs and must be 
operated in accordance with Regulations. All retailers wishing to sell tobacco 
products must register with the Office of Tobacco Control. 
Section 33 of the Public Health (Tobacco) Act 2002 to 2009 provides that a 
person who advertises or causes the advertisement of a tobacco product in 
contravention of Directive 2003/33/EC shall be guilty of an offence. 
 
HSE CEO Professor Brendan Drumm signed the Tobacco Free United (TFU) 
Charter and appealed to all health care professionals to always ask their patients 
and clients about their tobacco consumption and give them advice on how to quit.  
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Appendix 4 Data on smoking prevalence 
 
Percentage of respondents smoking by gender, age, social class and year  
            (1998, 2002, 2007) (Reproduced from the SLÁN Report 2008, pp 76) 
 
Men Women Total  
1998 
% 
2002 
% 
2007 
% 
1998 
% 
2002 
% 
2007 
% 
1998 
% 
2002 
% 
2007 
% 
Total 34 27 31 32 27 27 33 27 29 
Age Group 
18-29 42 29 38 44 31 32 43 30 35 
30-44 38 33 37 34 32 29 36 33 34 
45-64 29 23 23 26 25 27 28 24 25 
65+ 19 20 17 16 14 13 17 17 14 
Social Class 
1-2 30 19 24 31 19 23 30 19 24 
3-4 36 27 33 37 27 28 36 27 30 
5-6 39 33 34 38 38 41 39 35 37 
UNC** 32 32 35 27 33 20 30 33 25 
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Percentages of boys who report that they are current smokers 
 (Reproduced from the HBSC Report 2007) 
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Percentage of girls who report that they are current smokers 
 (Reproduced from the HBSC Report 2007) 
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Appendix 5 Abbreviations 
 
DoHC  Department of Health and Children 
 
ENSH  European Network of Smoke Free Health Care Service 
 
FCTC  Framework Convention on Tobacco Control  
 
GMS  General Medical Services 
 
HBSC  Health Behaviour and School aged Children Report 
 
HPH  Health Promoting Hospitals 
 
HSE  Health Service Executive 
 
ISAAC  International Study of Asthma and Allergies in childhood 
 
NICE  National Institute of Health and Clinical Excellence 
 
NCI  National Cancer Institute 
 
OTC  Office of Tobacco Control 
 
PCCC  Primary Community and Continuing Care 
 
QUALYS Quality adjusted life years 
 
RIFTFS Research Institute for a Tobacco Free Society 
 
SHS  Second hand smoke 
 
SLÁN  Survey of Lifestyle, Attitudes and Nutrition 
 
SPHE  Social Personal and Health Education 
 
STAG  Smoking Target Action Group  
 
WHO  World Health Organisation 
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